IP Verse

Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses Thereof

Patent No. EP3096785 (titled "Immunogenic Compositions Comprising Conjugated Capsular Saccharide Antigens And Uses Thereof") was filed by Pfizer on Jan 15, 2015. The application was issued on Sep 9, 2020.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
SK BIOSCIENCEJun 9, 2021ZWICKER
SANOFI PASTEURJun 8, 2021ZWICKER
MERCK SHARP & DOHMEJun 4, 2021VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3096785

PFIZER
Application Number
EP15708580A
Filing Date
Jan 15, 2015
Status
Granted And Under Opposition
Aug 7, 2020
Publication Date
Sep 9, 2020
External Links
Slate, Register , Google Patents